London, 24 April 2024 - Real estate services firm Cushman & Wakefield has further strengthened its UK Healthcare team with key appointments, including hiring Peter Farnes formerly a Senior Director at CBRE.
Cushman & Wakefield’s specialist UK Healthcare team provides Valuation & Advisory and transactional services in its Healthcare Markets business for national and international companies across the healthcare market. This includes care homes, seniors housing, private hospitals, medical clinics and GP practices, specialist care, childcare settings and other primary care entities.
Farnes has joined the Healthcare Markets team to bolster its market presence across the sector. Most recently at CBRE for 12 years, he has a strong track record of portfolio transactions as well as single asset acquisitions and disposals across the healthcare spectrum from care homes to medical. At Cushman & Wakefield he will be a Partner and a senior member of the transactional team, working closely with Tom Robinson - whose role as Head of Healthcare now spans both Valuation and Markets - as well as other key figures including James Hanson, Adam Lowe, David Kerr, and Amy King, Head of Seniors Housing.
Tom Robinson, Head of Healthcare at Cushman & Wakefield, said: “Peter is a strategic hire for us whose deep experience and relationships, especially in the care industry, complements the existing strengths of our transactional team. The timing is excellent as we move away from the muted investment volumes of 2023 and focus on the fundamentally-strong operator trading performance at hand. Sure enough, we’ve started to see increased activity, with portfolios on the move, a more bullish stance from global specialist investors and Private Equity coming back. This backdrop is surely the fuel needed for traditional money and new players looking to enter the market.”
Sophia Sham, a Partner who has been at Cushman & Wakefield for seven years, has been promoted to lead the Healthcare Valuation & Advisory team; one of the largest teams in the UK, providing data-led advice and commercial insight to clients ranging from regional to global players. In 2023, the team valued assets worth c.£20 billion in reported value, supporting clients from individual entrepreneurs to some of the largest specialist healthcare investors worldwide.
Cushman & Wakefield Makes Key UK Healthcare Appointments
Vikki McCrindle • 24/04/2024
INSIGHTS
Research
EMEA Data Centre Market Update
EMEA now totals to a massive 7.6GW of operational IT data centre capacity, a 10% rise from H1 2023. In addition, the region has 2.3GW capacity under construction and 6.6GW in planned stages.
Andrew Fray • 02/05/2024
Research
Life Sciences: Golden Triangle Lab Report
Inside our latest Life Sciences Lab Report you’ll find insight on investment volumes, leasing take up, lab supply and pipeline, and investment into life sciences real estate across Cambridge, London, and Oxford.
Jamie Renison • 02/05/2024
MarketBeat
Cushman & Wakefield MarketBeat reports analyse quarterly UK commercial property activity across office, retail and industrial real estate sectors as well as the Central London residential market. Find data on supply, demand and pricing trends at the market and submarket levels.
Edward Bavister • 29/04/2024
What's new
Cushman & Wakefield’s UK Valuation & Advisory Team Welcomes Partner and Head of Sustainability
Gillian Bowman joins from Knight Frank to take on the role.
Vikki McCrindle • 01/05/2024
Cushman & Wakefield Makes Key UK Healthcare Appointments
Real estate services firm Cushman & Wakefield has further strengthened its UK Healthcare team with key appointments, including hiring Peter Farnes formerly a Senior Director at CBRE.
Vikki McCrindle • 24/04/2024
Cushman & Wakefield Appoints Mark Hingston As Managing Director, Asset Services EMEA
Cushman & Wakefield has promoted Mark Hingston to Managing Director, Asset Services EMEA.
Richard Coleman • 22/04/2024